96 results
Page 3 of 5
8-K
EX-99.1
fi69iyicgrf08na
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.1
zyl0w
7 Nov 22
Viatris Reports Strong Third Quarter 2022 Results
7:41am
8-K
EX-99.1
byewcjck7yevbhfignd
8 Aug 22
Viatris Reports Strong Second Quarter 2022 Results
8:02am
8-K
EX-99.1
pf52cvo
9 May 22
Viatris Reports Strong First-Quarter 2022 Results
8:15am
S-3
94wsy o4o2z9i
6 May 22
Shelf registration
4:53pm
S-3ASR
uyd4fsrn 4xcpk
6 May 22
Automatic shelf registration
4:41pm
8-K
svw8qk8p lb
28 Feb 22
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-99.1
dsq68a7i1t0f4fjah
28 Feb 22
Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results and Issues 2022 Financial Guidance
8:24am
8-K
EX-99.1
jr42eoz2p4uwf12p8v
8 Nov 21
Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Board of Directors Declares Quarterly Dividend of Eleven Cents ($0.11) per Share
8:27am
DEF 14A
tyix 4r03bb
29 Oct 21
Definitive proxy
4:35pm
424B3
q9dl6f05f6qpadb i62
28 Sep 21
Prospectus supplement
9:26am
S-4
63v3y
10 Sep 21
Registration of securities issued in business combination transactions
5:01pm